PURPOSE OF REVIEW: We provide a long-term perspective of our experience with designing and managing a successful biorepository system. We include a brief history, a description of our current process, and lessons learned. RECENT FINDINGS: Biologic specimens, collected and stored as part of HIV-related research for years, are now being used for biomarker analyses that have important implications for both AIDS and non-AIDS events. If appropriately collected, documented, and stored, biospecimens are a valuable resource that can help answer current and future scientific questions. International networks must be able to monitor and adhere to country-specific specimen use regulations. Specimens for human DNA research need increased levels of privacy protection. Issues to consider when designing a biorepository system include expertise, communication, data management, technology, standardized methods and procedures, shipping, and specimen use policies. SUMMARY: As biorepositories are an integral part of research their design should not be an afterthought. Good designs consider all stages of research, and the most critical components are expertise and planning. Successful biorepository systems must have a balance of flexibility and standardization. The need for adaptable data management systems, whether commercial products or systems developed specifically for the network, should not be underestimated. Investment in appropriate technology, including a barcoding system with high-quality labels and printers, will pay off in the long term. To meet the needs of emerging technologies, it is becoming increasingly important to document the conditions at the time of specimen collection and processing. Regular communication between all components of the biorepository system is critical.
PURPOSE OF REVIEW: We provide a long-term perspective of our experience with designing and managing a successful biorepository system. We include a brief history, a description of our current process, and lessons learned. RECENT FINDINGS: Biologic specimens, collected and stored as part of HIV-related research for years, are now being used for biomarker analyses that have important implications for both AIDS and non-AIDS events. If appropriately collected, documented, and stored, biospecimens are a valuable resource that can help answer current and future scientific questions. International networks must be able to monitor and adhere to country-specific specimen use regulations. Specimens for human DNA research need increased levels of privacy protection. Issues to consider when designing a biorepository system include expertise, communication, data management, technology, standardized methods and procedures, shipping, and specimen use policies. SUMMARY: As biorepositories are an integral part of research their design should not be an afterthought. Good designs consider all stages of research, and the most critical components are expertise and planning. Successful biorepository systems must have a balance of flexibility and standardization. The need for adaptable data management systems, whether commercial products or systems developed specifically for the network, should not be underestimated. Investment in appropriate technology, including a barcoding system with high-quality labels and printers, will pay off in the long term. To meet the needs of emerging technologies, it is becoming increasingly important to document the conditions at the time of specimen collection and processing. Regular communication between all components of the biorepository system is critical.
Authors: Michael Weber; Birgitt Rabenau; Michael Stanisch; Albrecht Elsaesser; Vesselin Mitrovic; Christopher Heeschen; Christian Hamm Journal: Clin Chem Date: 2006-03-09 Impact factor: 8.327
Authors: Brian R Leyland-Jones; Christine B Ambrosone; John Bartlett; Matthew J C Ellis; Rebecca A Enos; Adekunle Raji; Michael R Pins; Jo Anne Zujewski; Stephen M Hewitt; John F Forbes; Mark Abramovitz; Sofia Braga; Fatima Cardoso; Nadia Harbeck; Carsten Denkert; Scott D Jewell Journal: J Clin Oncol Date: 2008-10-27 Impact factor: 44.544
Authors: Amy L McGuire; James Colgrove; Simon N Whitney; Christina M Diaz; Daniel Bustillos; James Versalovic Journal: Genome Res Date: 2008-10-29 Impact factor: 9.043
Authors: Lindsay G Wich; Heather K Hamilton; Richard L Shapiro; Anna Pavlick; Russell S Berman; David Polsky; Judith D Goldberg; Eva Hernando; Prashiela Manga; Michelle Krogsgaard; Hideko Kamino; Farbod Darvishian; Peng Lee; Seth J Orlow; Harry Ostrer; Nina Bhardwaj; Iman Osman Journal: Am J Transl Res Date: 2009-01-01 Impact factor: 4.060
Authors: D Abrams; Y Lévy; M H Losso; A Babiker; G Collins; D A Cooper; J Darbyshire; S Emery; L Fox; F Gordin; H C Lane; J D Lundgren; R Mitsuyasu; J D Neaton; A Phillips; J P Routy; G Tambussi; D Wentworth Journal: N Engl J Med Date: 2009-10-15 Impact factor: 91.245
Authors: Thomas M Deserno; Daniel Haak; Vincent Brandenburg; Verena Deserno; Christoph Classen; Paula Specht Journal: J Digit Imaging Date: 2014-12 Impact factor: 4.056
Authors: Clive Wasserfall; Anne-Marie Dyer; Cate Speake; Dana K Andersen; Kendall Thomas Baab; Melena D Bellin; James R Broach; Martha Campbell-Thompson; Vernon M Chinchilli; Peter J Lee; Walter G Park; Richard E Pratley; Jami L Saloman; Emily K Sims; Gong Tang; Dhiraj Yadav; Cemal Yazici; Darwin L Conwell Journal: Pancreas Date: 2022-07-01 Impact factor: 3.243